SEQUELAE, INC.
Profile
Company Names
SEQUELAE, INC.
Addresses
80 S 8TH ST #3100, MINNEAPOLIS, MN 55402
Phone Numbers
763-442-7383
Entity Type:
CORPORATION
Industry:
OTHER TECHNOLOGY
Year Incorporated:
2023
State Incorporated:
DELAWARE
Total Amount Raised:
$80,222,750.00
Number of Funding Rounds:
3
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
3
2025-11-07
$222,750.00
$1,485,000.00
$1,262,250.00
Equity
2
2024-04-25
$20,000,000.00
$20,000,000.00
$0.00
Equity
1
2023-04-18
$60,000,000.00
$60,000,000.00
$0.00
People
First Name
Middle Name
Last Name
Titles
Related Companies
GREGORY
JOHNSON
EXECUTIVE OFFICER
SOUTH AMERICAN SILVER CORP
| SINGULEX INC
| NORTHERN FREEGOLD RESOURCES LTD
| INTELLICYT CORP
| PIXELEXX SYSTEMS, INC.
| VERAN MEDICAL TECHNOLOGIES, INC.
| METALLIC MINERALS CORP.
| MIND + BODY RESEARCH, INC.
| CONTOURGLOBAL PLC
| BLOCK 5A HOLDING LLC
| BLOCK 6 HOLDING LLC
| BLOCK 13 HOLDING LLC
| BW-IGC, INC.
| SEQUELAE, INC.
AMY
SCHULMAN
DIRECTOR
ARSANIS, INC.
| SUONO BIO, INC.
| QUENTIS THERAPEUTICS, INC.
| GLYMPSE BIO, INC.
| CYCLERION THERAPEUTICS, INC.
| CARDURION PHARMACEUTICALS, INC.
| FRACTYL LABORATORIES INC.
| AMAGMA, INC.
| BYHEART, INC.
| QURALIS CORP
| FRACTYL HEALTH, INC.
| LYNDRA THERAPEUTICS, INC.
| THIRTY MADISON, INC.
| VOLASTRA THERAPEUTICS, INC.
| POLARIS PARTNERS X, L.P.
| SEQUELAE, INC.
| NOETIK INC.
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
Brokers
Broker Dealer
Broker CRD#
Recipient Name
Recipient CRD#

